Cargando…
Biomarker discovery for tuberculosis using metabolomics
Tuberculosis (TB) is the leading cause of death among infectious diseases, and the ratio of cases in which its pathogen Mycobacterium tuberculosis (Mtb) is drug resistant has been increasing worldwide, whereas latent tuberculosis infection (LTBI) may develop into active TB. Thus it is important to u...
Autores principales: | Yu, Yi, Jiang, Xin-Xin, Li, Ji-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986447/ https://www.ncbi.nlm.nih.gov/pubmed/36891238 http://dx.doi.org/10.3389/fmolb.2023.1099654 |
Ejemplares similares
-
Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data
por: Grissa, Dhouha, et al.
Publicado: (2016) -
Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023) -
Networks and Graphs Discovery in Metabolomics Data Analysis and Interpretation
por: Amara, Adam, et al.
Publicado: (2022) -
Editorial: Applications of metabolomics to the discovery of biomolecules from natural products
por: Choi, Young Hae, et al.
Publicado: (2023) -
Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review
por: Porter, Lachlan, et al.
Publicado: (2020)